Regenxbio
RGNX
RGNX
170 hedge funds and large institutions have $939M invested in Regenxbio in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 63 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
24% less capital invested
Capital invested by funds: $1.23B → $939M (-$292M)
39% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 36
Holders
170
Holding in Top 10
4
Calls
$5.93M
Puts
$6.95M
Top Buyers
| 1 | +$8.4M | |
| 2 | +$7.8M | |
| 3 | +$6.42M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.01M |
| 5 |
JP Morgan Chase
New York
|
+$4.28M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$6.29M | |
| 3 | -$5.5M | |
| 4 |
Millennium Management
New York
|
-$4.32M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$4.29M |